Skip to Main Content Go to Sitemap

Chia Wei Teoh

Title:
Staff Physician, Division of Nephrology
Designations:
MSc, MB B.Ch., BAO, LRCSI, MRCPI
Phone:
416-813-7654 ext. 202872
Email:
Chiawei.teoh@sickkids.ca
Alternate Contact Name:
Dana Debernyj
Alternate Phone:
416-813-6287
Alternate Email:
Dana.debernyj@sickkids.ca
U of T Positions:
Assistant Professor, Department of Paediatrics

Hospital Positions

Director
Renal Transplant 
Program

Research Positions

Project Investigator
SickKids Research Institute
 

Biography

Dr. Chia Wei Teoh joined the Division of Nephrology at The Hospital for Sick Children (SickKids) in 2017, as a Staff Physician and Assistant Professor of Paediatrics, Faculty of Medicine, University of Toronto. He completed his primary medical degree and specialist training in Paediatrics at the Royal College of Physicians of Ireland. He began his Paediatric Nephrology training there, while working at Our Lady’s Children’s Hospital, Crumlin and at Temple Street Children’s University Hospital in Dublin. He then completed a year of Paediatric Nephrology Fellowship at B.C. Children’s Hospital/University of British Columbia before joining the Paediatric Nephrology Fellowship program at SickKids/University of Toronto from 2014 to 2017. He was also a Transplant & Regenerative Medicine Centre fellow from 2015 to 2017. He completed a master of science degree at the Institute of Medical Science, University of Toronto studying the role of complement in calcineurin inhibitor-induced endothelial cell toxicity.

Dr. Teoh is a Paediatric Nephrologist and is the Director of the Renal Transplant Program at SickKids, and aims to integrate his clinical and research interests which include all aspects of paediatric renal transplantation and complement-mediated disorders. Dr. Teoh also participates in the glomerular disorder and hypertension clinical groups within the Division of Nephrology.

Research

Dr. Teoh’s research interests include all aspects of paediatric solid organ/kidney transplantation, with a focus on immunosuppression, complement-mediated injury in transplantation and improving long-term outcomes in paediatric transplantation.

Education and experience

  • 2017: M.Sc., Institute of Medical Science, University of Toronto, Toronto, ON, Canada
  • 2017: Clinician Investigator Program, University of Toronto, Toronto, ON, Canada
  • 2015–2017: Transplant & Regenerative Medicine Centre Fellowship, The Hospital for Sick Children, Toronto, ON, Canada
  • 2014–2017: Fellowship in Paediatric Nephrology, University of Toronto (The Hospital for Sick Children), Toronto, ON, Canada
  • 2013–2014: Fellowship in Paediatric Nephrology, University of British Columbia (BC Children’s Hospital), Vancouver, BC, Canada
  • 2014: Specialist Training in Paediatrics, The Royal College of Physicians of Ireland, Dublin, Ireland
  • 2008: Membership of The Royal College of Physicians of Ireland (Paediatrics), MRCPI, Dublin, Ireland
  • 2006: MB B.Ch. BAO, LRCSI, The National University of Ireland (Penang Medical College/Royal College of Surgeons in Ireland), Dublin, Ireland

Achievements

  • 2019: Chair Elect, Pediatric Group, Canadian Society of Transplantation
  • 2019: Member, Trillium Gift of Life Network (TGLN) Kidney/Pancreas Working Group
  • 2018–2019: Secretary/Treasurer, Pediatric Group, Canadian Society of Transplantation
  • 2019: Renal Professional Award, The Kidney Foundation of Canada, Ontario Branch
  • 2019: C Phillips Rance Nephrology Award of Merit, Division of Nephrology, The Hospital for Sick Children, Toronto

Publications

  1. Kim JK, Koyle MA, Raveendran L, Teoh CW, Chua ME, Ming JM, Farhat WA, Hebert D, Lorenzo AJ. Pediatric kidney transplant experience in Ontario: A review of division of the surgical and medical management across local tertiary care institutions. Canadian Journal of Kidney Health and Disease, 2020: Jun, 7: 1-11.
  2. Kim JK, Chua ME, Teoh CW, Lee MJ, Kesavan A, Hebert D, Lorenzo AJ, Farhat WA, Koyle MA. Assessment of prophylactic heparin infusion as a safe preventative measure for thrombotic complications in pediatric kidney transplant recipients weighing <20 kg. Pediatric Transplantation, 2019: Sept 23(6): e13512.  
  3. Teoh CW, Riedl M, Licht C. The alternative pathway of complement and the thrombotic microangiopathies. The Journal of Transfusion and Apheresis Science, 2016: Apr; 54: 220-231.
  4. Teoh CW, Robinson L.A, Noone DG. Perspectives on edema in childhood nephrotic syndromeAmerican Journal of Physiology: Renal Physiology, 2015: 309(7): F575-582.
  5. Medjeral-Thomas NR, O'Shaughnessy M, O'Regan JA, Traynor C, Flanagan M, Wong L, Teoh CW, Awan A, Waldron M, Cairns T, O'Kelly P, Dorman AM, Pickering MC, Conlon PJ, Coo HT: C3 GlomerulopathyClinicopathological features and predictors of outcome. Clinical Journal of the American Society of Nephrology, 2014: 9(1): 46-53

  • 2019–2021: Utilizing enhanced ultrasound as a monitoring strategy to improve outcomes in paediatric kidney transplantation
  • 2017–2020: Assessing Prevalence of Cognitive and Neuroanatomical Differences in Paediatric Kidney Transplant Recipients
  • 2017–2018: Longitudinal Profiling of Cell-free DNA and RNA for Non-invasive Monitoring of Paediatric Kidney Transplantations
  • 2016–2017: Long-term Survival in Childhood Solid Organ Transplants
  • 2013–2019: Non-invasive Monitoring of Pediatric Kidney Allograft Injury to Improve Diagnosis and Patient Outcome
Back to Top